Synmosa Biopharma Corporation (TPEX:4114)

Synmosa Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,248	14,499	14,706	16,021	7,016	6,814
Market Cap Growth	16.45%	-1.41%	-8.21%	128.36%	2.96%	20.87%
Enterprise Value	18,148	16,554	17,100	19,459	10,892	11,385
Last Close Price	32.40	30.68	30.79	34.75	15.05	14.33
PE Ratio	20.52	21.18	24.72	20.05	23.09	10.68
Forward PE	-	28.41	28.41	28.41	28.41	28.41
PS Ratio	2.66	2.61	2.86	3.65	2.17	2.24
PB Ratio	1.63	1.73	1.82	2.41	1.15	1.14
P/TBV Ratio	1.98	2.16	2.39	3.38	1.67	1.73
P/FCF Ratio	69.20	25.61	48.24	31.98	19.39	68.14
P/OCF Ratio	34.31	18.57	28.73	25.42	15.42	26.79
EV/Sales Ratio	2.97	2.98	3.33	4.44	3.37	3.75
EV/EBITDA Ratio	16.54	15.38	18.43	25.58	22.83	25.99
EV/EBIT Ratio	23.74	22.34	27.72	42.24	58.33	76.15
EV/FCF Ratio	77.30	29.24	56.09	38.84	30.10	113.85
Debt / Equity Ratio	0.28	0.30	0.30	0.51	0.57	0.62
Debt / EBITDA Ratio	2.50	2.37	2.56	4.32	7.15	8.30
Debt / FCF Ratio	11.96	4.50	7.98	6.70	9.57	37.02
Asset Turnover	0.47	0.46	0.45	0.41	0.31	0.32
Inventory Turnover	1.75	1.83	1.99	1.97	1.59	1.74
Quick Ratio	1.52	1.54	1.35	1.10	0.95	0.94
Current Ratio	2.45	2.42	2.14	1.73	1.64	1.91
Return on Equity (ROE)	6.03%	5.68%	5.49%	9.71%	1.93%	8.82%
Return on Assets (ROA)	3.76%	3.85%	3.36%	2.68%	1.13%	0.98%
Return on Invested Capital (ROIC)	5.95%	5.87%	4.76%	4.58%	1.61%	1.74%
Return on Capital Employed (ROCE)	6.80%	7.20%	6.40%	5.20%	2.20%	1.70%
Earnings Yield	4.74%	4.72%	4.04%	4.99%	4.33%	9.37%
FCF Yield	1.45%	3.91%	2.07%	3.13%	5.16%	1.47%
Dividend Yield	1.68%	1.78%	1.61%	1.31%	2.31%	1.28%
Payout Ratio	35.41%	33.41%	32.69%	18.60%	26.32%	7.16%
Buyback Yield / Dilution	-5.14%	-3.52%	-3.84%	0.79%	-2.35%	-9.76%
Total Shareholder Return	-3.46%	-1.74%	-2.22%	2.10%	-0.04%	-8.48%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.